Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Isotopia USA is thrilled to announce its new partnership with E Solutions and Comfort Systems USA to build out its North American headquarters and US GMP manufacturing center
  • USA - English

Isotopia  Logo

News provided by

Isotopia

07 Feb, 2024, 19:00 IST

Share this article

Share toX

Share this article

Share toX

INDIANAPOLIS, Ind.  , Feb. 7, 2024 /CNW/ -- Isotopia USA and E Solutions have signed commitments to design-build its state-of-the-art GMP manufacturing center. Isotopia plans to establish its US isotope manufacturing operations over the next 12 months and anticipates providing GMP-grade products to its key customers in Q4 2024. The facility will encompass 28,000 ft2 of cleanrooms, analytical and microbiological laboratories needed for high-volume production of Lutetium-177 n.c.a. (177Lu) and Terbium-161(161Tb) isotopes. These drug substances act as the critical ingredients of targeted nuclear medicine for improving cancer patients' overall survival and quality of life.

Isotopia USA CEO, Todd Hockemeyer stated:

"E Solutions and Comfort Systems have a reliable history of executing multiple FDA- regulated installations in the radiopharmaceutical industry on time and within budget. Just as importantly, their expertise in cleanroom technology, clean air ventilation and building management systems make them an important partner in ensuring our success completing this project."   

Greg Bielefeld, President of E Solutions, stated:

"Our team is very excited to extend our relationship with the world-class professionals at Isotopia. They are an industry leader in the production of cancer treatments, and we cannot be more proud to support them in their endeavor."

About Isotopia. 

Isotopia Molecular Imaging Ltd. is a dominant Lutetium (177Lu) Non-Carrier-Added supplier. Our multidisciplinary development team consists of nuclear pharmacists, radiochemists, nuclear engineers, and physicists. Together with our nuclear pharmacy, cyclotron facility, 177Lu production sites and sterile manufacturing plant, Isotopia is a well-established platform for managing the entire process from manufacturing through to delivery. Isotopia creates collaborations between the scientific and medical community to further develop and experiment with new markers for molecular therapy and imaging applications.

About E Solutions and Comfort Systems USA. 

E Solutions, a division of Comfort Systems, is a leading supplier of state-of-the-art cleanrooms and GMP laboratories, as well as shielded isolators and hotcells tailored for radioisotope and radiopharmaceutical manufacturing. Comfort Systems USA is a leading building and service provider for mechanical, electrical and plumbing systems.  In June, 1997, the company went public with 12 operating companies. Today, Comfort Systems is composed of more than 45 operating companies in over 170 locations across the United States delivering expert resources necessary to perform a range of services including process piping, modular construction, and building automation controls. 

Contact:
Isotopia USA
Todd Hockemeyer

CEO
[email protected]
E Solutions
Greg Bielefeld

President
[email protected]

Logo - https://mma.prnewswire.com/media/2335455/Isotopia_Logo.jpg

SOURCE Isotopia

Modal title

Also from this source

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160...

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.